Skip to content

Vaxcyte, Inc. PCVX Earnings yield

Earnings yield at other companies

Pfizer logo
PfizerPFE
6.8%
Merck & Co. logo
Merck & Co.MRK
3%-4.7pp
Moderna logo
ModernaMRNA
-15.9%-5.2pp
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
3%+0.6pp
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-10.8%-2.6pp
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
3.8%

Other financials

Income statement

See full
Operating income-$345.9M-91.3%
Net income-$320.6M-128%
EPS (diluted)-$2.30-121%

Balance sheet

See full
Cash & equivalents$262.3M-24.7%
Total debt$116.3M+33.5%
Total equity$3.0B-6.4%
Total assets$3.3B-0.9%

Cash flow

See full
Operating cash flow-$280.6M-68.8%
CapEx$2.1M-61.2%
Free cash flow-$282.7M-64.7%

Valuation

See full
Market cap$7.43B+72.0%
Enterprise value$7.28B+78.6%

Returns & leverage

See full
Return on equity-30.6%+37.9pp
Debt / equity0.0×
Current ratio7.5×-10.2×

Where this comes from

Calculated from Vaxcyte, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vaxcyte, Inc.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vaxcyte, Inc.'s earnings yield?
Vaxcyte, Inc. (PCVX) reported earnings yield of -11.3% in Q1 2026.
How has Vaxcyte, Inc.'s earnings yield changed year-over-year?
Vaxcyte, Inc.'s earnings yield decreased by 8.0% year-over-year, from -10.5% to -11.3%.
What is the long-term trend for Vaxcyte, Inc.'s earnings yield?
Over 5 years (2020 to 2025), Vaxcyte, Inc.'s earnings yield has grown at a 14.1% compound annual growth rate (CAGR), from -6.6% to -12.7%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.